Stefania Fieni

Stefania Fieni

Auto-generated profile, based on publicly available information

Stefania Fieni

Department of Medicine and Surgery (Capozzi, Monfardini, De Finis, Bontempo, Valenti, Scarpelli, Pasquo, Morganelli, Fieni, Berretta, Ghi), University Hospital of Parma, Parma, Italy

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2026 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Closed access
Vito Andrea CapozziVito Andrea Capozzi
Vito Andrea Capozzi
Giuseppe MagliettaGiuseppe Maglietta
Giuseppe Maglietta
LMLuciano Monfardini
Luciano Monfardini
AFAlessandra De Finis
Alessandra De Finis
PBPriscilla Bontempo
Priscilla Bontempo
TGTullio Ghi
Tullio Ghi

22 September 2026 in Placenta
Verified
Journal Article
Open access
GMGiovanni Morganelli
Giovanni Morganelli
CLCorinne Labadini
Corinne Labadini
CPCaterina Pavan
Caterina Pavan
MBMaria Teresa Baffa
Maria Teresa Baffa
MMMelissa Maugeri
Melissa Maugeri
SFStefania Fieni
Stefania Fieni
Histological chorioamnionitis frequently occurs at term in the absence of clinical signs of intrauterine inflammation. The diagnostic accuracy of suspected intraamniotic infection or inflammation (Triple I) criteria in term pregnancies remains unclear. To evaluate the diagnostic performance of suspected Triple I criteria for identifying histological chorioamnionitis at term. This retrospective case-control study included singleton term pregnancies (≥37 weeks) delivered between 2021 and 2024 at a tertiary referral center. Cases were defined by histological chorioamnionitis, and controls were randomly selected (1:1 ratio) among placentas without histological evidence of inflammation during the same study period. Diagnostic performance of suspected Triple I within the last 24 h before delivery was assessed using sensitivity, specificity, predictive values, likelihood ratios, and ROC curve analysis. Among 438 women (219 cases, 219 controls), suspected Triple I was present in 27.9% of cases. Triple I showed low sensitivity and high specificity (96.8%), with a positive likelihood ratio of 8.71 and an AUC of 0.623 (95% CI 0.571-0.675, p < 0.001). A positive result increased the post-test probability from 15% to approximately 61%, whereas a negative result only slightly reduced it. At multivariable analysis, gestational age at delivery (aOR 1.63, 95% CI 1.22-2.19), and fetal tachycardia (aOR 4.08, 95% CI 1.76-9.49) were independently associated with histological chorioamnionitis. At term, suspected Triple I criteria have limited sensitivity but high specificity for histological chorioamnionitis, supporting their use as a rule-in rather than rule-out tool. These findings highlight the need for improved diagnostic strategies integrating clinical parameters with biomarkers.